BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Callaghan C, Fanning LJ, Barry OP. p38δ MAPK: Emerging Roles of a Neglected Isoform. Int J Cell Biol 2014;2014:272689. [PMID: 25313309 DOI: 10.1155/2014/272689] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Pua LJW, Mai CW, Chung FF, Khoo AS, Leong CO, Lim WM, Hii LW. Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma. Int J Mol Sci 2022;23:1108. [PMID: 35163030 DOI: 10.3390/ijms23031108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
2 Wong NM, Frias E, Sigoillot FD, Letendre JH, Hild M, Wong WW. Engineering digitizer circuits for chemical and genetic screens in human cells. Nat Commun 2021;12:6150. [PMID: 34686672 DOI: 10.1038/s41467-021-26359-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Burton JC, Antoniades W, Okalova J, Roos MM, Grimsey NJ. Atypical p38 Signaling, Activation, and Implications for Disease. Int J Mol Sci 2021;22:4183. [PMID: 33920735 DOI: 10.3390/ijms22084183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
4 Germann UA, Alam JJ. P38α MAPK Signaling-A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease. Int J Mol Sci 2020;21:E5485. [PMID: 32751991 DOI: 10.3390/ijms21155485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wei TH, Hsieh CL. Effect of Acupuncture on the p38 Signaling Pathway in Several Nervous System Diseases: A Systematic Review. Int J Mol Sci 2020;21:E4693. [PMID: 32630156 DOI: 10.3390/ijms21134693] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
6 Li Y, Sui X, Hu X, Hu Z. Overexpression of KLF5 inhibits puromycin‑induced apoptosis of podocytes. Mol Med Rep 2018;18:3843-9. [PMID: 30106142 DOI: 10.3892/mmr.2018.9366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
7 Fang Y, Wang J, Wang G, Zhou C, Wang P, Zhao S, Zhao S, Huang S, Su W, Jiang P, Chang A, Xiang R, Sun P. Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer. Oncotarget 2017;8:26702-17. [PMID: 28460458 DOI: 10.18632/oncotarget.15804] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
8 Wada M, Canals D, Adada M, Coant N, Salama MF, Helke KL, Arthur JS, Shroyer KR, Kitatani K, Obeid LM, Hannun YA. P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment. Oncogene 2017;36:6649-57. [PMID: 28783172 DOI: 10.1038/onc.2017.274] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 7.4] [Reference Citation Analysis]
9 Yurtsever Z, Patel DA, Kober DL, Su A, Miller CA, Romero AG, Holtzman MJ, Brett TJ. First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochim Biophys Acta 2016;1860:2335-44. [PMID: 27369736 DOI: 10.1016/j.bbagen.2016.06.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
10 Marcotte R, Sayad A, Brown KR, Sanchez-Garcia F, Reimand J, Haider M, Virtanen C, Bradner JE, Bader GD, Mills GB, Pe'er D, Moffat J, Neel BG. Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance. Cell 2016;164:293-309. [PMID: 26771497 DOI: 10.1016/j.cell.2015.11.062] [Cited by in Crossref: 250] [Cited by in F6Publishing: 197] [Article Influence: 41.7] [Reference Citation Analysis]
11 Sulzbach DE Oliveira HS, Biolchi V, Richardt Medeiros HR, Bizerra Gandor Jantsch DB, Knabben DE Oliveira Becker Delving LK, Reckziegel R, Goettert MI, Brum IS, Pozzobon A. Effect of Helicobacter pylori on NFKB1, p38α and TNF-α mRNA expression levels in human gastric mucosa. Exp Ther Med 2016;11:2365-72. [PMID: 27284322 DOI: 10.3892/etm.2016.3213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
12 Liu X, Yang X, Zhu R, Dai M, Zhu M, Shen Y, Fang H, Sang A, Chen H. Involvement of Fra-1 in Retinal Ganglion Cell Apoptosis in Rat Light-Induced Retina Damage Model. Cell Mol Neurobiol 2017;37:83-92. [PMID: 27002720 DOI: 10.1007/s10571-016-0346-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
13 Zheng S, Yang C, Liu T, Liu Q, Dai F, Sheyhidin I, Lu X. Clinicopathological significance of p38β, p38γ, and p38δ and its biological roles in esophageal squamous cell carcinoma. Tumour Biol 2016;37:7255-66. [PMID: 26666822 DOI: 10.1007/s13277-015-4610-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
14 Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89:867-882. [PMID: 25690731 DOI: 10.1007/s00204-015-1472-2] [Cited by in Crossref: 393] [Cited by in F6Publishing: 499] [Article Influence: 56.1] [Reference Citation Analysis]
15 Norman P. Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs 2014;24:383-92. [DOI: 10.1517/13543784.2015.1006358] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
16 Babu KS, Morjaria JB. Emerging therapeutic strategies in COPD. Drug Discov Today 2015;20:371-9. [PMID: 25462534 DOI: 10.1016/j.drudis.2014.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]